Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-24-001791

Director sold 7,056 shares at $86.45 ($609,991)

  • Director acquired 7,056 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

STONE HEISZ LESLIE · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-08 Exercise or conversion : show line 1 in the form +7,056 $36.86 $260,107 34,036 D
2024-02-08 Sale : show line 2 in the form −7,056 $86.45 $609,991 26,980 D
Open-market sales · 7,056 sh · avg $86.45 · $609,991

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-02-08 Exercise or conversion : show line 3 in the form Director Stock Option (Right to Acquire) −7,056 $36.86 2024-05-11 7,056 0 D
Loading xslF345X05/doc4.xml…